Cardiovascular disease is the world’s leading cause of death
Advancing new therapies is slowed by one of the industry’s biggest barriers: patient recruitment.
- Older patients often bring multiple comorbidities
- Diversity gaps persist, despite regulatory pressure for broader inclusion
- Long trial durations heighten dropout risks
- Competition is fierce among sponsors targeting the same patient populations
The result? Missed milestones, strained budgets, and delayed delivery of treatments to patients who need them most.
OMNI CRS accelerates your cardiovascular enrollment with precision, compliance, and a performance marketing engine built for results
OMNI CRS operates as more than a referral vendor. We’re a strategic partner that delivers conversion-ready participants while safeguarding compliance and data integrity. Our innovative network unites digital outreach, real-world engagement, and advanced optimization to accelerate cardiovascular enrollment.
Our Impact in Cardiovascular Studies
79k+ cardiovascular leads
across our portfolio (9.5% of total)
Average of 540 qualified patients
referred per cardiovascular study
Single-study record
205,750 leads generated for one cardiovascular trial
Hypertension focus
9.6k leads across 12 studies
Supported trials
in heart failure, atrial fibrillation, and lipid disorders
Results That Move Trials Forward
When a leading CRO faced lagging enrollment in a large hypertension trial, OMNI CRS launched a diversity-first, multi-channel strategy. Within months:
- Timelines were cut by 40%.
- Minority participation increased by 25%.
- Retention improved through ongoing patient engagement touchpoints.
This is what happens when compliance-first processes and a powerful recruitment engine work in tandem.
Partner With OMNI CRS to Advance Cardiovascular Research
Your cardiovascular trial deserves a recruitment partner that can deliver speed, scale, and diversity—without compromising compliance or quality. OMNI CRS brings the expertise, data, and proven performance to get you there.